|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/24 | |||
| A61K 39/395 |
| (11) | Patento numeris | 3004167 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14734671.2 |
| Europos patento paraiškos padavimo data | 2014-05-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/040360 |
| Data | 2014-05-30 |
| (87) | Numeris | WO 2014/194274 |
| Data | 2014-12-04 |
| (30) | Numeris | Data | Šalis |
| 201361829082 P | 2013-05-30 | US |
| (72) |
ARNETT, Heather A., US
ESCOBAR, Sabine S., US
KING, Chadwick T., CA
LIM, Ai Ching, US
NARAYANAN, Saravanakumar, US
WEINREB, Paul H., US
PEDERSON, Nels E., US
|
| (73) |
Kiniksa Pharmaceuticals, Ltd.,
Clarendon House 2 Church Street, Hamilton HM 11,
BM
|
| (54) | ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS |
| ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS |